More than five decades after the Controlled Substances Act of 1970 relegated psilocybin to Schedule I—placing it...
Muslim
The COVID-19 pandemic, which fundamentally altered the trajectory of the 21st century, continues to leave an indelible...
In the rapidly advancing landscape of precision medicine, the role of the clinical scientist has never been...
As the popularity of glucagon-like peptide-1 (GLP-1) receptor agonists—such as semaglutide and tirzepatide—continues to skyrocket, the medical...
Published July 5, 2026 Yoga Journal’s archives series provides a curated window into our history, resurfacing foundational...
The pharmaceutical industry is witnessing a seismic shift in the treatment of metabolic diseases. At the American...
Date: June 2026 Location: Chicago, IL Byline: Medical Correspondence Desk Main Facts: A Landmark Year for Breast...
Breast cancer is not a monolithic disease but a complex spectrum of biological subtypes, each defined by...
In a significant stride toward refining endovascular interventions for patients with severe vascular disease, the Medical University...
On July 1, 2026, the Centers for Medicare & Medicaid Services (CMS) will embark on an unprecedented...
